PAR paradigm biopharmaceuticals limited..
Add to My Watchlist 1.72% ! 28.5¢

The Ghosh Study - PART 1, page-18

  1. Beaza79
    5,514 Posts.
    lightbulb Created with Sketch. 762
    clock Created with Sketch.
    16/06/25
    23:14
    Post #: 79455310
    A lot more drugs get bought out after phase 2 than phase 3 so this is bullshit, sorry Mozz.
    PAR Price at posting: 29.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 8  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Agreement for Sale of Mount Mason Project to Gold Valley Yilgarn
right-arrow Created with Sketch.
NEWS New Positive Interim Data in Phase 2 Study of SNT-5505 in Myelofibrosis
right-arrow Created with Sketch.
NEWS Pathological Complete Response Recorded in ACCENT Trial of Advanced Pancreatic Cancer
right-arrow Created with Sketch.
NEWS FBR Executes Engineering Service Agreement with Samsung Heavy Industries
right-arrow Created with Sketch.
NEWS Ministerial Approval Grants Provisional Authorisation for Battery Anode Material Facility
right-arrow Created with Sketch.
NEWS High-Grade Gold Hits Extend Major Lodes at Kpali Prospect in Ghana
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
28.5¢ 		Change
-0.005(1.72%) 		Mkt cap ! $110.9M
Open High Low Value Volume
29.0¢ 29.0¢ 28.5¢ $1.681K 5.8K

Buyers (Bids)

No. Vol. Price($)
4 36459 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 10706 2
View Market Depth
Last trade - 10.21am 17/06/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.